Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identifying Unmonitored Tone Drift in Patient Education Materials Transcribed to a Lower Reading Level by a Large Language Model.

Neurosurgery·2026
Same author

Machine learning and deep learning-based drug-drug interactions prediction: a systematic review focused on anticancer drugs.

NPJ precision oncology·2026
Same author

Gold Nanoparticles in Central Nervous System Diseases: Recent Progress, Challenges, and Therapeutic Opportunities.

Nano letters·2026
Same author

International multi-center study to quantify the effect of deep venous drainage after surgical resection of Spetzler-Martin Grade II-III brain arteriovenous malformations.

Neurosurgical review·2026
Same author

Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE.

AJNR. American journal of neuroradiology·2026
Same author

Endovascular and Microsurgical Treatment for Middle Cerebral Artery Bifurcation Aneurysms: Experience From 10 High-Volume United States Cerebrovascular Centers.

Neurosurgery·2026
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
查看所有相关文章

相关实验视频

Updated: Sep 9, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791

开发用于免疫治疗的aptamer向mRNA

Alexandra R Paul1,2, Khuloud T Al-Jamal3,4

  • 1Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR.

Methods in molecular biology (Clifton, N.J.)
|August 28, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种新型的aptamer药物输送平台,用于向T细胞输送向信使RNA (mRNA). 该平台显著增强了免疫细胞中的mRNA转染,提高了免疫治疗潜力.

关键词:
适应剂流细胞测量凝电泳免疫疗法核酸转染提供mRNA

更多相关视频

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.8K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

相关实验视频

Last Updated: Sep 9, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.8K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

科学领域:

  • 生物技术
  • 免疫学
  • 药物输送系统

背景情况:

  • 传递 RNA (mRNA) 的疗法依赖于选择性蛋白质表达.
  • 有效地将mRNA输送到目标细胞,特别是免疫细胞,对于免疫治疗至关重要.
  • 目前的mRNA输送方法往往缺乏特异性,限制了治疗效果.

研究的目的:

  • 开发和验证一种针对T细胞的新型aptamer药物递送平台,以增强mRNA递送到免疫细胞.
  • 为了证明在T细胞中以aptamer为媒介的mRNA转染的效率,用于免疫治疗.
  • 建立用于mRNA治疗的aptamer选择,结合和表征的协议.

主要方法:

  • 针对T细胞的aptamer选择和特征.
  • 对OX40mRNA的合.
  • 转染的aptamer-mRNA构建成小鼠体内细胞T细胞.
  • 在CD4+和CD8+T细胞中量化mRNA转染效率.

主要成果:

  • 在小鼠T细胞中,针对T细胞的aptamer显著提高了mRNA转染效率.
  • 与非向mRNA相比,CD4+细胞转染率增加了四倍,CD8+细胞转染率增加了七倍.
  • 获得了成功的合和表征.

结论:

  • 开发的以aptamer为基础的平台可以有效地将mRNA传递给T细胞以进行免疫治疗.
  • 这种有针对性的输送方法增强了免疫细胞的传染,为下一代mRNA疗法提供了有希望的策略.
  • 该平台的模块化允许定制以针对其他细胞类型或受体.